Loading viewer...
investor_presentation
Format: PDF investor_presentation
Perrigo's February 2023 strategic offsite presentation outlining Phase 2 of its optimization and acceleration initiatives. The company addresses supply chain reinvention, recent acquisitions including HRA Pharma, and regulatory developments such as OTC oral contraceptive approvals, amid broader economic and geopolitical headwinds.
investor_presentation
84 Pages
Xcel Energy
Phibro Animal Health Investor Presentation — February 2020
investor_presentationinvestor_presentation
12 Pages
Phibro Animal Health Corporation